Facebook Instagram Linkedin Youtube
Home Tags ELC-301

Tag: ELC-301

Elicera’s CEO: “TO2 is a highly attractive opportunity to increase ownership...

Elicera Therapeutics receives partial payment of 0,5 MEur from EIC

Elicera’s CEO: ”2025 is a crucial year for us”

Elicera_CompleteResponse

Elicera’s CEO: “All signs of the disease disappeared in the first...

Elicera’s CEO: “One of the biggest milestones in our history”

Adjutec prepares for clinical trial

Elicera’s first clinical CAR T-Cell study CARMA set to begin

Full speed ahead for Elicera in 2024

Full speed ahead for Elicera in 2024

Elicera's CEO: " iTANK has great potential in treating solid tumours"

Elicera’s CEO: ” iTANK has great potential in treating solid tumours”

Elicera_EU_patent

Elicera Therapeutics receives important EU patent

Elicera uppdaterar i samband med Cancer Immunotherapy Month

Elicera gives an update in Cancer Immunotherapy Month

123Page 1 of 3
© BioStock 2025